Traws Market Capitalization from 2010 to 2024

TRAW Stock   5.02  0.31  5.82%   
Traws Pharma Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap is likely to outpace its year average in 2024.
Check Traws Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Traws Pharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 15.6 K or Total Revenue of 193.2 K, as well as many indicators such as Price To Sales Ratio of 1.1 K, Dividend Yield of 0.0 or PTB Ratio of 30.16. Traws financial statements analysis is a perfect complement when working with Traws Pharma Valuation or Volatility modules.
  
Check out the analysis of Traws Pharma Correlation against competitors.
For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

Latest Traws Pharma's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of Traws Pharma over the last few years. It is Traws Pharma's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Traws Pharma's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 8.85 M10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Traws Market Capitalization Regression Statistics

Arithmetic Mean390,464,086
Geometric Mean221,930,228
Coefficient Of Variation134.37
Mean Deviation320,666,125
Median251,199,619
Standard Deviation524,652,146
Sample Variance275259.9T
Range2B
R-Value0.48
Mean Square Error229495.9T
R-Squared0.23
Significance0.07
Slope55,747,896
Total Sum of Squares3853638.2T

Traws Market Capitalization History

2024434.3 M
2023414.5 M
2022339.8 M
20211.1 B
2020B
2019136.7 M
2018217.5 M

About Traws Pharma Financial Statements

Traws Pharma investors use historical fundamental indicators, such as Traws Pharma's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Traws Pharma. Please read more on our technical analysis and fundamental analysis pages.
Traws Pharma is entity of United States. It is traded as Stock on NASDAQ exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.